It has been known that rotenone and 1-methyl-4-phenylpyridinium ion (MPP(+), a metabolite of MPTP), which inhibit mitochondrial complex I, are useful tools for parkinsonian models in vertebrates such as primates and rodents. Planarian, an invertebrate flatworm, has a high potential for regeneration, and dopamine plays a key role in its behavior. In the present study, we examined a cloned planarian, the GI strain from Dugesia japonica. Planarians that were treated with rotenone or MPTP underwent autolysis and individual death in a concentration- and time-dependent manner. In addition, these effects induced by rotenone or MPTP were inhibited by several antiparkinsonian drugs and caspase inhibitors. These results suggest that the degeneration of planarian dopaminergic system induced by rotenone or MPTP may be mediated through caspase-like activation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1254/jphs.92.137 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Alpha-Synuclein Effects on Mitochondrial Quality Control in Parkinson's Disease.
Biomolecules
December 2024
Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
The maintenance of healthy mitochondria is essential for neuronal survival and relies upon mitochondrial quality control pathways involved in mitochondrial biogenesis, mitochondrial dynamics, and mitochondrial autophagy (mitophagy). Mitochondrial dysfunction is critically implicated in Parkinson's disease (PD), a brain disorder characterized by the progressive loss of dopaminergic neurons in the substantia nigra. Consequently, impaired mitochondrial quality control may play a key role in PD pathology.
View Article and Find Full Text PDFExploring Acoustic Detection of α-Synuclein Fibrils.
Protein J
December 2024
Univ. Grenoble Alpes, CEA, Leti, Clinatec, 38000, Grenoble, France.
Over the past decades, the incidence of Parkinson's disease (PD) cases has doubled in industrialized countries. While patients over 70 years old still represent more than half of the cases, the disease is increasingly affecting younger individuals. Environmental factors have been implicated, such as the effects of certain pesticides or chemicals on neurons, such as rotenone or 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
View Article and Find Full Text PDFDevelopment of novel aza-stilbenes as a new class of selective MAO-B inhibitors for the treatment of Parkinson's disease.
Bioorg Chem
December 2024
University of Ljubljana, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Aškerčeva 7, 1000 Ljubljana, Slovenia. Electronic address:
Article Synopsis
- Parkinson's disease (PD) is a progressive neurodegenerative disorder linked to the loss of dopamine-producing neurons, and MAO-B inhibitors may help manage its symptoms and reduce oxidative stress.
- Researchers developed a library of azastilbene-based compounds, screening them to identify candidates with strong inhibitory effects on human MAO-B, achieving low nanomolar potency with one compound (IC = 42 nM).
- The study also demonstrated that these compounds can decrease the production of reactive oxygen species in a cell model and protect against motor dysfunction and neuronal loss in PD model mice, indicating their potential as effective treatments for PD and similar disorders.
Lactoferrin Protects Against Rotenone-Induced Toxicity in Dopaminergic SH-SY5Y Cells through the Modulation of Apoptotic-Associated Pathways.
J Mol Neurosci
September 2024
Department of Biological Sciences, School of Medical and Life Sciences, Sunway University, Selangor Darul Ehsan, 47500, Bandar Sunway, Malaysia.
Parkinson's disease (PD) is a common motor neurodegenerative disease that still lacks effective therapeutic options. Previous studies have reported that lactoferrin exhibited neuroprotective effects in cellular and animal models of PD, typically induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or 1-methyl-4-phenylpyridinium (MPP) synthetic toxin. However, the neuroprotective capacity of lactoferrin in the rotenone-induced cellular model of PD remains relatively less established.
View Article and Find Full Text PDFUse of phytocanabinoids in animal models of Parkinson's disease: Systematic review.
Neurotoxicology
December 2024
Department of Veterinary Medicine, Federal Rural University of Pernambuco, Brazil.
This systematic review was carried out with the aim of evaluating the use of medicinal Cannabis for the treatment of Parkinson's disease in experimental models. Furthermore, we sought to understand the main intracellular mechanisms capable of promoting the effects of phytocannabinoids on motor disorders, neurodegeneration, neuroinflammation and oxidative stress. The experimental models were developed in mice, rats and marmosets.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!